The global intrauterine devices (IUDs) market is witnessing robust expansion, driven by rising awareness of long-acting reversible contraception (LARC), supportive government initiatives, and technological innovation. Valued at US$ 4.7 Bn in 2024, the market is projected to grow at a CAGR of 10.6% from 2025 to 2035, surpassing US$ 14.2 Bn by the end of 2035.
An intrauterine device (IUD) is a small, T-shaped birth control device inserted into the uterus by a healthcare provider to prevent pregnancy for up to 10 years or longer, depending on the product type. IUDs are among the most widely used forms of long-acting reversible contraception due to their high efficacy, convenience, and minimal maintenance.
There are two primary types of IUDs: copper IUDs and hormonal (levonorgestrel) IUDs. Both feature a flexible plastic frame and strings for removal. While copper IUDs are hormone-free and use copper to prevent fertilization, hormonal IUDs release levonorgestrel to thicken cervical mucus and thin the uterine lining.
With shifting reproductive health priorities and increasing demand for reliable contraceptive options, the global IUD industry is positioned for sustained long-term growth.
Explore the highlights and essential data from our Report in this sample – https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86611
Market Overview
The intrauterine devices market is expanding as global awareness around contraception and reproductive health continues to improve. Educational campaigns, digital health information platforms, and proactive healthcare counseling have contributed significantly to the rising adoption of IUDs.
Government-backed family planning programs and international collaborations with organizations such as the World Health Organization and United Nations Population Fund have strengthened the distribution and accessibility of IUDs worldwide. These initiatives particularly target rural and underserved populations to reduce unintended pregnancies and unsafe abortions.
In addition, product innovation—including IUDs incorporating shape memory alloy components to reduce mal-positioning and uterine perforation risks—is further supporting market expansion.
Key Drivers of Market Growth
- Rising Awareness Among Women
One of the primary drivers of the intrauterine devices market is the increasing awareness of IUD applications and benefits. Compared to short-term contraceptive methods such as oral pills, IUDs offer long-term protection without requiring daily compliance.
Women are increasingly recognizing the benefits of:
- High contraceptive efficacy (over 99%)
- Long duration of protection (3–10 years)
- Reversibility upon removal
- Minimal daily maintenance
This growing awareness is driving higher acceptance rates across diverse age groups.
- Government Initiatives to Prevent Unintended Pregnancies
Governments worldwide are promoting LARCs, including IUDs, as cost-effective and reliable contraceptive solutions. Public health programs often provide free or subsidized access to IUDs through hospitals and community health centers.
In the United States, policies under Title X and the Affordable Care Act have expanded insurance coverage for contraceptive methods, significantly improving affordability and accessibility.
- Availability of Advanced Products
Continuous R&D investments have led to next-generation IUD designs offering improved safety and patient comfort. Clinical advancements and better insertion techniques have also increased provider confidence in recommending IUDs.
Key Players and Industry Leaders
The intrauterine devices market is moderately consolidated, with major players focusing on partnerships, geographic expansion, and product innovation.
Prominent companies operating in the market include:
- AbbVie
- Bayer AG
- CooperSurgical Inc
- DKT INTERNATIONAL
- EUROGINE, S.L.
- Mona Lisa N.V.
- OCON Medical Ltd
- Pregna International Limited
- Prosan International BV
- SMB Corporation of India
- Other Prominent Players
These companies are actively collaborating with hospitals, gynecology clinics, and public health programs to expand their footprint.
Recent Developments
Innovation continues to shape the competitive landscape. In May 2023, Sebela Pharmaceuticals announced positive Phase 3 results for its investigational Copper 175 mm² IUD, demonstrating a 99.0% efficacy rate over three years.
In January 2025, 49Care launched Yanae, a French-invented copper IUD featuring a flexible inserter designed to enable easier and less painful insertion. The product became available across Canadian pharmacies at a competitive retail price.
These developments reflect the industry’s commitment to improving patient comfort, safety, and accessibility.
New Opportunities and Challenges
Opportunities
- Expansion into emerging markets with limited contraceptive access
- Increasing demand among younger women (ages 21–34)
- Integration of telehealth consultations for contraceptive counseling
- Development of hormone-free and low-dose variants
Challenges
- Cultural and religious barriers in certain regions
- Misconceptions regarding side effects
- Regulatory complexities across countries
- High upfront insertion costs in private healthcare systems
Despite these challenges, favorable reimbursement frameworks and expanding public health coverage are mitigating adoption barriers.
Market Trends & Innovations
Dominance of Hormonal IUDs
Based on product type, hormonal (levonorgestrel) IUDs dominate the global market. Their ability to provide both contraception and additional health benefits—such as reduced menstrual bleeding and cramps—makes them highly appealing.
Hormonal IUDs typically provide protection for 3 to 7 years, offering convenience and dual therapeutic benefits.
Technological Advancements
- Shape memory alloy frames to reduce displacement
- Smaller insertion devices for improved patient comfort
- Improved biocompatible materials
- Enhanced provider training programs
These innovations are increasing patient satisfaction and improving long-term adoption rates.
Buy this Premium Research Report to explore detailed market trends – https://www.transparencymarketresearch.com/checkout.php?rep_id=86611<ype=S
Market Segmentation
By Product Type
- Copper IUDs
- Hormonal (levonorgestrel) IUDs
By Age Group
- 15–20
- 21–34
- 35–44
- 45+
By End-user
- Hospitals
- Gynecology clinics
- Community healthcare centers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Key Trends for the Future
- Growing preference for long-term contraceptive solutions
- Increased adoption among younger demographics
- Product innovation focused on patient comfort
- Government-supported awareness campaigns
- Expansion of pharmacy-based distribution models
As healthcare systems prioritize preventive care and women’s health, IUD adoption is expected to accelerate significantly.
Future Outlook
The intrauterine devices market is set for substantial growth through 2035. Rising global awareness, improved product innovation, and strong governmental support are expected to sustain a double-digit growth trajectory.
With increasing investment in R&D, expanding healthcare access in developing regions, and growing acceptance of LARCs as a preferred contraceptive method, the market is projected to exceed US$ 14.2 Bn by 2035.
Hormonal IUDs will likely continue to dominate the market, while copper IUDs will maintain strong demand among women seeking hormone-free options.
Overall, the industry outlook remains highly optimistic, with technology, policy support, and shifting societal attitudes collectively shaping the next decade of growth.
Important FAQs with Answers
How big was the global intrauterine devices market in 2024?
The market was valued at US$ 4.7 Bn in 2024.
How large will the market be by 2035?
It is projected to exceed US$ 14.2 Bn by 2035.
What is driving the market growth?
Rising awareness among women and government initiatives aimed at reducing unintended pregnancies are key drivers.
What is the expected CAGR from 2025 to 2035?
The market is anticipated to grow at a CAGR of 10.6%.
Which region leads the market?
North America is expected to hold the largest share during the forecast period.
Who are the major players?
Leading companies include AbbVie, Bayer AG, CooperSurgical Inc, DKT INTERNATIONAL, EUROGINE, S.L., Mona Lisa N.V., OCON Medical Ltd, Pregna International Limited, Prosan International BV, and SMB Corporation of India.
More Related Reports-
Sleep Apnea Devices Market: https://www.transparencymarketresearch.com/sleep-apnea-devices-market.html
Medical Devices Outsourcing Market: https://www.transparencymarketresearch.com/medical-devices-outsourcing-market.html
Chromoendoscopy Agents Market: https://www.transparencymarketresearch.com/chromoendoscopy-agents-market.html
Renal Denervation Devices Market: https://www.transparencymarketresearch.com/renal-denervation-devices-market.html
About Us Transparency Market Research
Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. The firm scrutinizes factors shaping the dynamics of demand in various markets. The insights and perspectives on the markets evaluate opportunities in various segments. The opportunities in the segments based on source, application, demographics, sales channel, and end-use are analysed, which will determine growth in the markets over the next decade.
Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision-makers, made possible by experienced teams of Analysts, Researchers, and Consultants. The proprietary data sources and various tools & techniques we use always reflect the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in all of its business reports.
Contact Us
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Leave a Reply